Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck less: Net Income Attributable to Noncontrolling Interests ($M) ($M)
Postgres DB financial_values
Latest, Q2 2026
-2
Period ended Jun 30, 2026
Change on a year earlier
-300.0%
1 in Q2 2025
History
66 quarters
Since Q1 2009
Sources
63
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Merck Less: Net Income Attributable to Noncontrolling Interests ($M) ($M), quarterly Q1 2009–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_nci
See every metric in the Merck KPI table. Data updated Oct 26, 2026.